Mouabbi, Jason A. http://orcid.org/0000-0001-8689-6845
Hassan, Amy
Lim, Bora
Hortobagyi, Gabriel N.
Tripathy, Debasish
Layman, Rachel M.
Article History
Received: 13 December 2021
Accepted: 7 March 2022
First Online: 26 March 2022
Declarations
:
: Jason A. Mouabbi: Consulting fees from GE Healthcare, Cardinal Health and Genentech. Any Hassan: Consulting fees for AIM Specialty Health, Oncology Pathways Program. Bora Lim: Consultation fees from Pfizer, Novartis, AstraZeneca and Prime Oncology Program. Research support from Puma Biotechnology, Merck, Genentech. Gabriel N. Hortobagyi: Research support from Novartis. Consulting fees from Novartis. Debasish Tripathy: Research support from Novartis and Pfizer. Consulting fees from Novartis, Pfizer, Exact Sciences, Gilead, GlaxoSmithKline and AstraZeneca. Rachel M. Layman: Research support from Pfizer, Eli Lilly, Novartis, GlaxoSmithKline, Puma, Zentalis and Celcuity. Consulting fees from Pfizer, Eli Lilly, Novartis and Celcuity.